Ethical considerations of genetic presymptomatic testing for huntington's disease

Journal of Hospital Marketing and Public Relations

Volumn 19, Issue 2, 2009, Pages 129-141

  Coustasse, Alberto ^a   Pekar, Alicia ^a   Sikula, Andrew ^a   Lurie, Sue ^b  

^a MARSHALL UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Ethics; Genetic testing; HD; Huntington's disease; Presymptomatic testing

Indexed keywords

ANAMNESIS; ANXIETY; ARTICLE; BENEFICENCE; COGNITION; DEPRESSION; DETERIORATION; DISTRESS SYNDROME; EMOTION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; HUNTINGTON CHOREA; JUSTICE; MEDICAL ETHICS; MOTIVATION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; SOCIAL SUPPORT; SUICIDE;

ADULT; BIOETHICAL ISSUES; FEMALE; GENETIC TESTING; HUMANS; HUNTINGTON DISEASE; INFANT, NEWBORN; PREGNANCY; PRINCIPLE-BASED ETHICS;

EID: 70449671389     PISSN: 15390942     EISSN: 15390934     Source Type: Journal    
DOI: 10.1080/15390940903041583     Document Type: Article

References (42)

1. Adam, O., & Jankovic, J. (2008). Symptomatic treatment of Huntington's disease. Neurotherapeutics: Journal of the American Society for Experimental NeuroTherapeutics 5: 181-197.
2. Almqvist, E., Brinkman, R., Hayden, M., Wiggins, S., & Canadian Collaborative Study of Predictive Testing. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clinical Genetics 64: 300-309.
3. American Medical Association. (2001). Principles of medical ethics. Chicago: American Medical Association.
4. Arthur, J., & Shaw, W. (1979). Justice and economic distribution. Englewood Cliffs, NJ: Prentice Hall.
5. Aubeeluck, A., & Buchaman, H. (2007). The Huntington's disease quality of life battery for carers: Reliability and validity. Clinical Genetics 71(5): 434-445.
6. Beauchamp, T., & Childress, J. (2001). Principles of biomedical ethics (5th ed.). New York: Oxford University Press.
7. Betancourt, J., Green, A., & Carillo, J. (2002). Cultural competence in health care: Emerging frameworks and practical approaches, New York: Commonwealth Fund.
8. Binedell, J., & Soldan, J. (1997). Nonparticipation in Huntington's disease predictive testing: Reasons for caution in interpreting findings. Journal of Genetic Counseling 6(4): 419-432.
9. Bombard, Y., Penziner, E., Decolongon, J., Klimek, M., Creighton, S., Suchowersky, O., et al. (2007). Managing genetic discrimination: Strategies used by individuals found to have the Huntington disease mutation. Clinical Genetics 17(3): 220-231.
10. Burgess, M. (2001). Beyond consent: Ethical and social issues in genetic testing. Nature Reviews 2: 147-151.
11. Burke, W., Pinsky, L., & Press, N. (2001). Categorizing genetic tests to identify their ethical, legal, and social implications. American Journal of Medical Genetics 106: 233-240.
12. Chapman, E. (2002). Ethical dilemmas in testing for late onset conditions: Reactions to testing and perceived impact on other family members. Journal of Genetic Counseling 11(5): 351-367.
13. Cox, S., & Mckellin, W. (1999). "There's this thing in our family": Predictive testing and the construction of risk for Huntington disease. Sociology of Health and Illness 21(5): 622-646.
14. Craufurd, D., & Harris, R. (1986). Ethics of predictive testing for Huntington's chorea: The need for more information. British Medical Journal 293: 249-251.
15. Dawson, S., Krisitijanson, L., Toye, C., & Flett, P. (2004). Living with Huntington's disease: Need for supportive care. Nursing & Health Sciences 6(2): 123-130.
16. Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., et al. (2003). Psychological distress in the 5-year period after predictive testing for Huntington's disease. European Journal of Human Genetics 11: 30-38.
17. Duncan, R., Gillam, L., Savulescu, J., Williamson, R., Rogers, J., & Delatycki, M. (2008). "You're one of us now": Young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics Part C (Seminars in Medical Genetics) 148C: 47-55.
18. European Community Huntington's Disease Collaborative Study Group. (1993). Ethical and social issues in presymptomatic testing for Huntington's disease: A European community collaborative study. Journal of Medical Genetics 30: 1028-1035.
19. Hamilton, R., Bowers, B., & Williams, J. (2005). Disclosing genetic test results to family members. Journal of Nursing Scholarship 37(1): 18-24.
20. Huggins, M., Bloch, M., Kanani, S., Quarrell, O., Theilman, J., et al. (1990). Ethical and legal dilemmas arising during predictive testing for adult-onset disease: The experience of Huntington disease. American Journal of Human Genetics 47: 4-12.
21. Hursthouse, R. (2003). Virtue ethics. Stanford Encyclopedia of Philosophy. Stanford, CA: Stanford University Press.
22. Keenan, K., Miedzybrodzka, Z., Van Teijlingen, E., Mckee, L., & Simpson, S. (2007). Young people's experiences of growing up in a family affected by Huntington's disease. Clinical Genetics 71(2): 120-129.
23. Kenney, C., Hunter, C., Davidson, B., & Jankovic, J. (2007). Short-term effects of tetrabenazine on chorea associated with Huntington's disease. Movement Disorders 22(1): 10-13.
24. Larsson, M., & Luszcz, M., Bui, T., & Wahlin, T. (2006). Depression and suicidal ideation after predictive testing for Huntington's disease: A two-year follow-up study. Journal of Genetic Counseling 15(5): 361-374
25. Licklederer, C., Wolff, G., & Barth, J. (2008). Mental health and quality of life after genetic testing for Huntington disease: A long-term effect study in Germany. American Journal of Medical Genetics 146A: 2078-2085.
26. Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing for Huntington's disease: An update of the literature. Journal of Neurology, Neurosurgery & Psychiatry 69: 574-578. (Pubitemid 30802079)
27. Morrison, E. (2006). Ethics in health administration, Sudbury, MA: Jones and Bartlett. National Center for Biotechnology Information (NCBI). (2008). Huntington disease. Retrieved February 20, 2009, from http://www.ncbi.nlm.nih. gov/books/ bv.fcgi?highlight=huntington%20disease&rid=gnd.section.207
28. Pakenham, K., Goodwin, V., & Macmillan, J. (2004). Adaptation to being at risk for Huntington's disease and the availability of genetic testing: Application of a stress and coping model. Psychology, Health and Medicine 9(3): 380-397.
29. Quaid, K., Sims, S., Swenson, M., Harrison, J., Moskowitz, C., Stepanov, N., et al. (2008). Living at risk: Concealing risk and preserving hope in Huntington disease. Journal of Genetic Counsel 17: 117-128.
30. Robins Wahlin, T.-B. (2007). To know or not to know: A review of behavior and suicidal ideation in preclinical Huntington's disease. Patient Education and Counseling 65: 279-287.
31. Skirton, H. (2005). Huntington's Disease: A nursing perspective. Medsburg Nursing 14(3): 167-173.
32. Soldan, J., Street, E., Gray, J., Binedell, J., & Harper, P. (2000). Psychological model for presymptomatic test interviews: Lessons learned from Huntington's disease. Journal of Genetic Counseling 9(1): 15-31.
33. Summers, J. (1989). Managers face conflicting values. Journal of Health Care Material Management 7(5): 80-83.
34. Taylor, S. (2004). Predictive genetic test decisions for Huntington's disease: Context, appraisal and new moral imperatives. Social Science & Medicine 58: 137-149.
35. Terrenoire, G. (1992). Huntington's disease and the ethics of genetic prediction. Journal of Medical Ethics 18: 79-85.
36. Tibben, A., Duivenvoorden, H., Niermeijer, M., Van Der Vlis, M., Roos, R., & Verghage, F. (1994). Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosomatic Medicine 56: 526-532.
37. Timman, R., Bonke, B., Stijjnen, T., Tibben, A., & Maat-Kievit, A. (2008). Estimating decreased risks for Huntington disease without a test. Genetic Epidemiology 23: 281-287.
38. van Duijn, E., Kingma, E., & van der Mast, R. (2007). Psychopathology in verified Huntington's disease gene carriers. Journal of Neuropsychiatry & Clinical Neurosciences 19(4): 441-448.
39. Walker, F. (2007). Huntington's disease. The Lancet 369: 218-228. (Pubitemid 46107685)
40. Wexler, N. (1992). The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders. FASEB Journal 6: 2820-2825.
41. Williams, J., Schutte, D., Evers, C., & Holkup, P. (2000). Redefinition: Coping with normal results from predictive gene testing for neurodegenerative disorders. Research in Nursing & Health 23: 260-269.
42. Witjes-Ańe, M.-N., Zwinderman, A., Tibber, A., van Ommen, G.-J., & Roos, R. (2002). Behavioral complaints in participants who underwent predictive testing for Huntington's disease. Journal of Medical Genetics 39: 857-862.